Prospective randomized pilot study of Y90 +/− sorafenib as bridge to transplantation in hepatocellular carcinoma
Laura Kulik(Northwestern University), Riad Salem(Northwestern University), Talia Baker(University of Utah), Jonathan Cotliar(Harbor–UCLA Medical Center), Sean Koppe(Northwestern University), Robert J. Lewandowski(Society of Interventional Radiology), Mary F. Mulcahy(Northwestern University), Michaël Abécassis(University of Arizona), Patrice Al‐Saden(Northwestern University), Daniel Ganger(Northwestern University), J. Karp(Northwestern University), Mario E. Lacouture(Garden City Community College), Ali Habib(Northwestern University), Michaël Vouche(Université Libre de Bruxelles)
Cited by 92
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k